Life ScienceCompany
Where is Kymab headquartered?
Kymab is headquartered in Cambridge, United Kingdom.
What sector is Kymab in?
Kymab is a life science company.
When was Kymab founded?
Kymab was founded in 2010.
Kymab is headquartered in Cambridge, United Kingdom.
Kymab is a life science company.
Kymab was founded in 2010.
The Bennet Building (B930), Babraham Research Campus,
Cambridge,
CB22 3AT
United Kingdom,
+44 (0)1223 833301
www.kymab.com
Kymab is a clinical-stage biopharmaceutical company developing fully human monoclonal antibody therapeutics with a focus on immune-mediated diseases and immuno-oncology using its proprietary, integrated platforms collectively called IntelliSelect®. Kymab’s IntelliSelect Transgenic platforms contain a full diversity of human antibodies, making them the most comprehensive antibody platforms available. Kymab was founded in 2010 and is based in Cambridge, United Kingdom.
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.